Navigation Links
Brookdale Announces First Quarter 2009 Results; CFFO of $0.49 per Share
Date:5/6/2009

risk of loss of property pursuant to our mortgage debt and long-term lease obligations; the possibilities that changes in the capital markets, including changes in interest rates and/or credit spreads, or other factors could make financing more expensive or unavailable to us; the risk that we may be required to post additional cash collateral in connection with our interest rate swaps; the risk that continued market deterioration could jeopardize certain of our counterparties' obligations; changes in governmental reimbursement programs; our limited operating history on a combined basis; our ability to effectively manage our growth; our ability to maintain consistent quality control; delays in obtaining regulatory approvals; our ability to integrate acquisitions into our operations; competition for the acquisition of assets; our ability to obtain additional capital on terms acceptable to us; a decrease in the overall demand for senior housing; our vulnerability to economic downturns; acts of nature in certain geographic areas; terminations of our resident agreements and vacancies in the living spaces we lease; increased competition for skilled personnel; increased union activity; departure of our key officers; increases in market interest rates; environmental contamination at any of our facilities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against us; the cost and difficulty of complying with increasing and evolving regulation; and other risks detailed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect our management's views as of the date of this press release and/or the associated ear
'/>"/>
SOURCE Brookdale Senior Living Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Brookdale Announces Third Quarter Common Stock Dividend of $0.50
2. Brookdale Announces Third Quarter 2007 Release and Earnings Call
3. Brookdale Announces Third Quarter 2007 Results
4. Brookdale Senior Living Announces Enhanced Web Site
5. Brookdale Announces Fourth Quarter Common Stock Dividend of $0.50
6. Brookdale Senior Living Announces Changes in Senior Management and Board of Directors
7. Brookdale Announces Fourth Quarter and Full Year 2007 Release and Earnings Call
8. Brookdale Announces Fourth Quarter and Full Year 2007 Results
9. Brookdale to Present at Citi Small & Mid-Cap Conference on March 17
10. Brookdale to Present at Lehman Global Healthcare Conference on March 19
11. Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 2015 , ... North American Seminars will present seventeen ... . These seventeen courses are pre-approved for CME credit for Physical therapists, ... the Older Adult , August 22, 2015 - August 23, 2015 presented ...
(Date:7/28/2015)... Orange, NJ (PRWEB) , ... July 28, 2015 , ... ... on the sidelines – or in your easy chair? Luckily, there are plenty of ... Kadimcherla, MD , an orthopedic spine surgeon at Atlantic Spine Center . ...
(Date:7/28/2015)... ... ... President of the Veterans Fund of the United States, managing the United Veteran Beacon House ... a campaign to help homeless Veterans by giving them “A hand up – not a ... the UVBH assists and supports Vets through the Veterans Fund of the United States ...
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical Medicine ... in order to offer his patients a new system of care utilizing laser therapy ... Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and typically ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s ... EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is ... things can get messy in a hurry. In a 46-page draft guidance released in ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4
... progression, mouse study suggests , , MONDAY, April 14 (HealthDay ... cholesterol and one is an anti-inflammatory -- may be ... presented at the American Association for Cancer Research annual ... and the statin Lipitor, when used together or alone, ...
... Kimmel Cancer Center at Thomas Jefferson University in ... blood pressure medications might help prevent the spread ... laboratory that one type of pressure-lowering drug called ... growth and causes cell death. , In earlier ...
... Real-Time In Vivo Data via Quantitative ... ... Inc., a leader,in fluorescence in vivo imaging, today announced the commercial ... is based on VisEn,s,proprietary Fluorescence Molecular Tomography (FMT(TM)) technology,platform, and combined ...
... 14 HealthFusion, a,national clearinghouse for ... center operation customer satisfaction excellence under ... Center Program(SM). This distinction,acknowledges a strong ... to provide "An Outstanding Customer Service ...
... As the first of the,nation,s 78 million baby boomers ... health care work force that is too small and ... new report from the Institute of,Medicine. The report calls ... providers -- not just specialists -- in the basics ...
... Denise Kehoe has joined,medication therapy management (MTM) company ... new role, she will manage and oversee the,expansion ... the country., Kehoe brings more than 15 ... PharmMD. She recently served as national strategic,executive of ...
Cached Medicine News:Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 2Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 3Health News:Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find 2Health News:VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 3Health News:Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis 2Health News:PharmMD Announces Denise Kehoe as Vice President of Business Development 2
(Date:7/27/2015)... 20, 2015 Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ... Device Regulation in Asia/Pacific Markets Seminar" conference to ... Medical Device market is well established, the next growth ... China , together with other countries in this ... of implementing, their own medical device regulations. This seminar ...
(Date:7/27/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/65t478/gprotein_coupled ... "G-Protein Coupled Receptors Market: Global Industry Analysis, Size, ... report to their offering. ... on of assay type, therapeutic area, and geography. ... been categorized into six major segments: cAMP assays, ...
(Date:7/27/2015)... , July 27, 2015 ... Situ Hybridization Market Study (2014-2019) by Type (DNA ISH, ... Others), By End User (Hospitals, Pharma & Biotech Companies, ... valued at $554.4 million 2014 and is estimated to ... 4.2% during the forecast period, 2014 to 2019. ...
Breaking Medicine Technology:Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3
... Oct. 3, 2011 To help frustrated nighttime nasal ... chronic nasal congestion and trouble with sleep, the makers ... to identify the 20 Most Congested Cities in the ... metropolitan areas where residents are most challenged by congestion ...
... MURRIETA, Calif., Oct. 3, 2011 ... recently took delivery of their long-awaited WASP® (Walk ... Module.  The acquisition was concomitant with the inauguration ... ongoing efforts to optimize patient care by consolidating ...
Cached Medicine Technology:20 Most Congested Cities in U.S. Unveiled 220 Most Congested Cities in U.S. Unveiled 320 Most Congested Cities in U.S. Unveiled 4COPAN WASP® Lands at Prestigious Boston Medical Center 2COPAN WASP® Lands at Prestigious Boston Medical Center 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: